Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pilot Study of Neoadjuvant Chemotherapy of FIRINOX for Patients With Borderline Resectable Pancreatic Cancer

NCT02148549 is registered in ClinicalTrials.gov with Wakayama Medical University as lead sponsor.

NCT NCT02148549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02148549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pilot Study of Neoadjuvant Chemotherapy of FIRINOX for Patients With Borderline Resectable Pancreatic Cancer
Lead sponsor
Wakayama Medical University
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
February 28, 2017
Enrollment
10 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

patients with borderline resectable pancreatic cancer